Anatomical distribution of sodium-dependent [3H]naloxone binding sites in rat brain

Synapse

Volumn 35, Issue 4, 2000, Pages 256-264

  Sim Selley, Laura J ^a,c   Xiao, Ruoyu ^b   Childers, Steven R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bed nucleus of the stria termina lis; Locus coeruleus; Mu opioid receptor; Nucleus tractus solitarius; Parabrachial nucleus; Periaqueductal gray

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZAMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; N ETHYLMALEIMIDE; NALOXONE; NALTRINDOLE; SODIUM; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; LOCUS CERULEUS; MALE; NONHUMAN; PARABRACHIAL NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; CELL MEMBRANE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ETHYLMALEIMIDE; GUANYLYL IMIDODIPHOSPHATE; KINETICS; MALE; NALOXONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SODIUM; TISSUE DISTRIBUTION; TRITIUM;

EID: 0033973082     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(20000315)35:4<256::AID-SYN3>3.0.CO;2-7     Document Type: Article

References (49)

1. Aghajanian GK. 1978. Tolerance of locus coeruleus neurones to morphine and suppression by clonidine. Science 276:186-188.
2. Alden M, Besson JM, Bernard JF. 1994. Organization of the efferent projections from the pontine parabrachial area to the bed nucleus of the stria terminalis and neighboring regions: a PHA-L study in the rat. J Comp Neurol 341:289-314.
3. Bals-Kubik R, Shippenberg TS, Herz A. 1990. Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β-endorphin in the rat. Eur J Pharmacol 175:63-69.
4. Bellet M, Elghozi JL, Meyer P, Pernollet MG, Schmitt H. 1980. Central cardiovascular effects of narcotic analgesics and enkephalins in rats. Br J Pharmacol 71:365-369.
5. Bernard JF, Alden M, Besson JM. 1993. The organization of the efferent projections from the pontine parabrachial area to the amygdaloid complex: a Phaseolus vulgaris leucoagglutinin (PHA-L) study in the rat. J Comp Neurol 329:201-229.
6. Ceresa BP, Limbird LE. 1994. Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of α2-adrenergic receptor-G-protein interactions: a negative charge at amino acid residue 79 forecasts α2A-adrenergic receptor sensitivity to allosteric modulation by monovalent cations and fully effective receptor/G-protein coupling. J Biol Chem 269: 29557-29564.
7. Chamberlain NL, Saper CB. 1992. Topographic organization of cardiovascular responses to electrical and glutamate microstimulation of the parabrachial nucleus in the rat. J Comp Neurol 326:245-262.
8. Chen Y, Mestek A, Liu J, Hurley JA, Yu L. 1993. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
9. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-4002.
10. 3 Opiate receptor binding in the mouse and rat. Eur J Pharmacol 226:15-20.
11. Childers SR. 1984. Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide. J Pharmacol Exp Ther 230:684-691.
12. 11H]-ATP as substrate. J Pharmacol Exp Ther 11:161-171.
13. Childers SR, Jackson JL. 1984. pH selectivity of N-ethylmaleimide reactions with opiate receptor complexes in rat brain membranes. J Neurochem 43:1163-1170.
14. Childers SR, Snyder SH. 1980. Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J Neurochem 34:583-593.
15. Corbett AD, Paterson SJ, Kosterlitz HW. 1993. Selectivity of ligands for opioid receptors. In: Herz A, editor. Handbook of experimental pharmacology: opioids I. Berlin: Springer-Verlag, p 645-679.
16. Costa T, Lang J, Gless C, Herz A. 1990. Spontaneous association between opioid receptors and GTP-binding proteins in native membranes: specific regulation by antagonists and sodium ions. Mol Pharmacol 37:383-394.
17. Denavit-Saubie M, Champagnat J, Zieglgansberger W. 1978. Effects of opiates and methionine enkephalin on pontine and bulbar respiratory neurones of the cat. Brain Res 155:55-67.
18. Fields HL, Anderson SD. 1978. Evidence that raphe-spinal neurons mediate opiate and midbrain stimulation-produced analgesia. Pain 5:333-349.
19. Fields HL, Basbaum AI. 1978. Brainstem control of spinal paintransmission neurons. Ann Rev Physiol 40:217-248.
20. Goodman R, Pasternak GW. 1985. Visualization of μ1 opiate receptors in rat brain by using a computerized autoradiography. Proc Natl Acad Sci USA 82:6661-6677.
21. Hassen AH, Feuerstein G, Faden AI. 1982. μ Receptors and opioid cardiovascular effects in the NTS of rat. Peptides 3:1031-1037.
22. Herkenham M, Pert CB. 1982. Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J Neurosci 2:1129-1149.
23. Herz A, Albus K, Metys J, Schubert P, Teschemacher H. 1970. On the central sites of action of morphine and fentanyl. Neuropharmacol 9:539-551.
24. Horstman DA, Brandon S, Wilson AL, Guyer CA, Cragoe CA, Limbird LE. 1990. An aspartate conserved among G-protein receptors confers allosteric regulation of alpha(2)-adrenergic receptors by sodium. J Biol Chem 265:21590-21595.
25. Hoshino S, Kikkawa S, Takahashi K, Itoh H, Kaziro Y, Kwawsaki H, Suzuki K, Katada T, Ui M. 1990. Identification of sites for alkylation by N-ethylmaleimide and pertussis toxin-catalyzed ADP-ribosylation on GTP-binding proteins. FEBS Lett 276:227-231.
26. Koski G, Streaty RA, Klee WA. 1982. Modulation of sodium-sensitive GTPase by partial opiate agonists. J Biol Chem 257:14035-14040.
27. Kosten TA. 1994. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol 254: 59-63.
28. Maldonado R, Koob GF. 1993. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605:128-138.
29. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. 1988. Anatomy of CNS opioid receptors. Trends Neurosci 11:306-314.
30. Mayer P, Schulzeck S, Kraus J, Zimprich A, Hollt V. 1996. Promoter region and alternatively spliced exons of the rat μ-opioid receptor gene. J Neurochem 66:2272-2278.
31. Mraovitch S, Kumada M, Reis DJ. 1982. Role of the nucleus parabrachialis in cardiovascular regulation in cat. Brain Res 232:57-75.
32. Nijssen PCG, Childers SR. 1987. Characteristics of sodium-induced increase in opiate antagonist binding sites in rat brain membranes. Eur J Pharmacol 135:355-364.
33. Pasternak GW, Wilson HA, Snyder SH. 1975. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. Mol Pharmacol 11:340-351.
34. Pert CB, Snyder SH. 1974. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol Pharmacol 10:868-879.
35. Petty MA, DeJong W. 1982. Cardiovascular effects of β-endorphin after microinjection into the nucleus tractus solitarii of the anesthetized rat. Eur J Pharmacol 81:449-457.
36. Rossi CG, Leventhal L, Pan YX, Cole J, Su W, Bodnar RJ, Pasternak GW. 1997. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6β-glucuronide antinociception. J Pharmacol Exp Ther 281:109-114.
37. Selley DE, Nestler EJ, Breivogel CS, Childers SR. 1997. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Brain Res 746:10-18.
38. Shahrestanifar MS, Howells RD. 1996. Sensitivity of opioid receptor binding to N-substituted maleimides and methanethiosulfonate derivatives. Neurochem Res 21:1295-1299.
39. Shahrestanifar M, Wang WW, Howells RD. 1996. Studies on inhibition of μ and δ opioid receptor binding by dithiothreitol and N-ethylmaleimide. J Biol Chem 271:5505-5512.
40. Shinoda M, Katada T, Ui M. 1990. Selective coupling of purified alpha-subunits of pertussis toxin-substrate GTP-binding proteins to endogenous receptors in rat brain membranes treated with N-ethylmaleimide. Cell Signal 2:403-414.
41. Sim LJ, Joseph SA. 1994. Efferents of the opiocortin-containing region of the commissural nucleus tractus solitarius. Peptides 15:169-174.
42. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
43. 35S]GTPγS autoradiography in rat brain. J Neurosci 16:2684-2692.
44. Simon EJ, Groth J. 1975. Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions. Proc Natl Acad Sci USA 2:2404-2407.
45. Simon EJ, Hiller JM, Groth J, Edelman I. 1975. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect. J Pharmacol Exp Ther 192:531-537.
46. Thompson RC, Mansour A, Akil H, Watson SJ. 1993. Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11:903-913.
47. 0 with mu-opioid receptors in guinea pig striatal membranes pretreated with micromolar concentrations of N-ethylmaleimide. J Neurochem 54:841-848.
48. Wang J-B, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. 1994. Human μ opiate receptor: cDNA and genomic clones, pharmacological characterization and chromosomal assignment. FEBS Lett 338:217-222.
49. Zukin RS, Walczak S, Makman MH. 1980. GTP modulation of opiate receptors in regions of rat brain and possible mechanism of GTP action. Brain Res 186:238-244.